PharmaNews

Yingbin Deng, Druck Ausrüstung Kraft-Druck GmbH, Michael Sabranski, Kai Hübel(University Hospital Cologne), Yuxin Chen, Christian Hoffmann(Hochschule für Angewandte Wissenschaften Kiel), Stefan Esser, Marcus Hentrich(Red Cross Hospital), Jan Siehl(Endokrinologikum), Til R. Kiderlen
Oncology Research and Treatment
January 1, 2017
10.1159/000464155
Cited by 0

Related Papers

Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist
|Blood|2003|717
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
|Blood|2018|421
Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies
|JAMA|2011|323
Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial)
|Journal of Clinical Oncology|2017|248